Nordwand Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000
Closed -$2.44K 132
2024
Q3
$2.44K Buy
+1,000
New +$2.44K ﹤0.01% 116